Borovikov Artem, Marakhonov Andrey, Murtazina Aysylu, Davydenko Kseniya, Filatova Alexandra, Galeeva Nailya, Kadnikova Varvara, Ogorodova Natalya, Gorodilova Daria, Kanivets Ilya, Pyankov Denis, Zherdev Konstantin, Petel'guzov Aleksandr, Zubkov Pavel, Polyakov Alexander, Shchagina Olga, Skoblov Mikhail
Research Centre for Medical Genetics, Moscow, Russia.
Genomed, Moscow, Russia.
Front Genet. 2024 Aug 13;15:1435493. doi: 10.3389/fgene.2024.1435493. eCollection 2024.
Multiple osteochondromas (MO) is a rare autosomal dominant skeletal disorder characterized by the development of multiple benign tumors known as osteochondromas. The condition is predominantly caused by loss-of-function variants in the or genes, facilitating relatively precise clinical diagnosis through established diagnostic criteria. Despite this, a notable percentage of MO cases (10%-20%) remains unresolved after sequencing coding regions and copy number analysis of both genes. In our study, we identified mosaic structural variants in two patients who initially yielded negative results on standard genetic analysis for MO. Specifically, mosaic deletions affecting exons 8-11 and exons 2-11 in the gene were detected. RNA analysis was performed in one case, while both cases underwent genome sequencing. To date, only six mosaic copy number variations have been reported in association with MO, representing a minority among known variants in both genes. Our report provides a detailed analysis of these findings, highlighting the significance of advanced genetic testing techniques in detecting mosaic variants in the genes.
多发性骨软骨瘤(MO)是一种罕见的常染色体显性遗传性骨骼疾病,其特征是出现多个被称为骨软骨瘤的良性肿瘤。该病症主要由 或 基因的功能丧失变异引起,通过既定的诊断标准有助于进行相对精确的临床诊断。尽管如此,在对这两个基因的编码区进行测序和拷贝数分析后,仍有相当比例(10%-20%)的MO病例无法得到明确诊断。在我们的研究中,我们在两名最初MO标准基因分析结果为阴性的患者中鉴定出了嵌合结构变异。具体而言,检测到影响 基因外显子8-11和外显子2-11的嵌合缺失。对其中一例进行了RNA分析,两例均进行了基因组测序。迄今为止,仅报道了6例与MO相关的嵌合拷贝数变异,在这两个基因的已知变异中占少数。我们的报告对这些发现进行了详细分析,强调了先进基因检测技术在检测 基因嵌合变异中的重要性。